Prometrium Pediatric (Under 12): Caregiver Administration Guidance

Is Prometrium Approved for Children Under 12?

Prometrium is not FDA-approved for any indication in children under age 12. The FDA label covers secondary amenorrhea and endometrial protection in postmenopausal women receiving estrogen replacement, and no pediatric dosing section exists in the official prescribing information for this age band. Caregivers should document that the prescription is explicitly off-label and confirm the specialist's rationale before dispensing.

What the FDA Label Actually Says

The Prometrium prescribing information filed with the FDA states that safety and efficacy in pediatric patients have not been established. The full label is publicly available through the FDA's drug database. No dose table, weight-based calculation, or pediatric pharmacokinetic data appear in the approved labeling for patients under 12.

Why Physicians Prescribe It Off-Label in Young Children

Off-label use does not mean unsupported use. Pediatric endocrinologists sometimes prescribe micronized progesterone in children under 12 for situations such as:

• Hormonal suppression trials in girls with central precocious puberty when GnRH analogs are not accessible or tolerated
• Adjunct hormonal support during evaluation of congenital adrenal hyperplasia
• Neonatal or early-infantile seizure protocols where progesterone's neurosteroid metabolite allopregnanol has shown anticonvulsant properties in preclinical and early clinical work

A 2019 review in Pediatric Neurology examined allopregnanolone's role in neonatal seizure management and cited GABAergic mechanisms as the proposed pathway. Research on neurosteroids in early seizure management is indexed on PubMed. This does not constitute FDA approval, but it explains why a board-certified specialist may choose this agent.

Understanding the Drug: Micronized Progesterone Basics

Prometrium is micronized progesterone suspended in peanut oil inside a gelatin capsule. Micronization reduces particle size to improve gastrointestinal absorption compared with non-micronized formulations. After oral dosing in adults, peak serum progesterone concentrations occur at 3 hours, with a half-life of approximately 16 to 18 hours. Pharmacokinetic data in adults are summarized in the FDA labeling referenced above.

The Peanut Oil Warning: Non-Negotiable Allergy Check

Every caregiver must confirm the child has no known peanut allergy before the first dose and before every refill. Prometrium capsules contain peanut oil as the suspension vehicle. Anaphylaxis is possible in sensitized individuals. The Endocrine Society's clinical practice guidelines on pediatric hormonal therapy consistently note excipient allergy screening as a pre-treatment requirement. The Endocrine Society's guidelines are hosted at endocrine.org.

If a peanut allergy is identified after the prescription is written, contact the prescriber immediately. Compounding pharmacies can prepare progesterone in alternative oil vehicles, but compounded formulations require separate quality and dosing verification.

How Progesterone Works in a Child's Body

Progesterone binds to nuclear progesterone receptors and also acts as a precursor to the neurosteroid allopregnanolone, which is a positive allosteric modulator of GABA-A receptors. In simple terms, it can calm neuronal excitability. This is why sedation is among the most commonly reported side effects. GABA-A receptor modulation by neurosteroids is reviewed in detail at PubMed.

Children may experience more pronounced CNS effects per milligram than adults because their blood-brain barrier permeability and receptor density differ from mature adult physiology.

Caregiver Administration: Step-by-Step

Giving Prometrium correctly on every dose protects the child from both under-dosing and over-exposure. These steps apply to the oral capsule form. If the prescriber orders a compounded liquid or suppository, separate instructions from the compounding pharmacy take precedence.

Before the First Dose

1. Verify the prescription states the child's weight in kilograms and the dose in milligrams. Confirm with the pharmacist that the dispensed strength matches.
2. Read the peanut oil warning aloud with any co-caregiver who may give doses.
3. Note the prescribed schedule. Prometrium is most often dosed at bedtime in adults to take advantage of its sedative effect; this same rationale often applies to pediatric off-label use.
4. Store capsules in the original amber container at room temperature, 68°F to 77°F (20°C to 25°C). Do not refrigerate. Refrigeration can cause the peanut oil to congeal inside the capsule, altering dissolution.

Administering the Capsule to a Young Child

Prometrium capsules are not scored for splitting. The 100 mg capsule is the smallest commercially available strength. For children requiring doses below 100 mg, a compounded formulation is necessary. Never puncture, cut, or dissolve a Prometrium capsule unless the prescriber and pharmacist have confirmed the clinical appropriateness of this technique and provided written instructions.

If the child can swallow capsules whole, give with 4 to 6 ounces of water. Give with a small amount of food if nausea occurs, although food can slightly alter absorption timing. Drug absorption and food interaction data for progesterone are summarized in pharmacokinetic studies indexed on PubMed.

For children who cannot swallow capsules:

• Ask the prescribing pharmacist whether the contents can be mixed into a small volume of applesauce or pudding. This is an off-label technique and must be explicitly authorized in writing.
• Compounded oral suspensions (typically 25 mg/mL or 50 mg/mL in flavored vehicle) are the preferred alternative for young children who cannot swallow capsules.

Missed Dose Protocol

Give the missed dose as soon as the caregiver notices, provided the next scheduled dose is at least 2 hours away. If the next dose is within 2 hours, skip the missed dose and resume the regular schedule. Never double a dose. Document missed doses in a medication log to share at the next specialist visit.

Dosing Principles for Children Under 12

No standardized weight-based dosing table exists for Prometrium in children under 12 because no manufacturer or regulatory body has established one. The prescribing specialist derives doses from:

• Published case series and small clinical trials in pediatric populations
• Pharmacokinetic modeling from adult data, adjusted for body surface area or weight
• Institutional protocols at academic children's hospitals

A practical dosing framework used by some pediatric endocrinologists begins with a low starting dose (roughly 5 to 10 mg/day orally in children weighing 10 to 20 kg) and titrates upward based on serum progesterone trough levels, clinical response, and tolerance. This framework is not FDA-endorsed and must be individualized. The Endocrine Society's position is that hormonal therapy in children requires specialist supervision and regular reassessment. See Endocrine Society guidelines at endocrine.org.

Weight-Based Versus Fixed Dosing

For hormonal applications such as precocious puberty suppression, endocrinologists often target a serum progesterone level rather than a fixed milligram dose. Target trough levels in early-puberty suppression trials have ranged from 1 to 5 ng/mL in small published series. For neurological applications (seizure protocols), dose ranges vary considerably by center and by seizure type.

Compounded Versus Branded

Branded Prometrium capsules come only in 100 mg and 200 mg. Most children under 12 who genuinely need progesterone will require a compounded strength. Compounding must occur at an accredited pharmacy (PCAB accreditation or equivalent) to reduce variability risk. Inform the specialist if the pharmacy changes so dose verification can occur.

Side Effects Caregivers Must Know

Side effects documented in the adult labeling are the starting point for anticipating effects in children. Because pediatric data are sparse, caregivers should apply a higher vigilance standard.

CNS and Sedation Effects

Drowsiness is the most common effect. In the Women's Health Initiative Memory Study ancillary data, progesterone-containing regimens were associated with measurable changes in cognitive performance metrics, underscoring the drug's CNS activity. The WHI Memory Study is available through PubMed.

In children, watch for:

• Difficulty staying awake during the day, especially if dosing occurs at times other than bedtime
• Slurred speech or unsteady gait (sign of over-sedation; call the prescriber the same day)
• Mood changes, irritability, or depressive symptoms lasting more than 3 to 5 days

Gastrointestinal Effects

Nausea and abdominal cramping occur in a minority of patients. Giving the dose with a small snack may reduce nausea without significantly reducing efficacy, though the evidence base for this in children is limited to adult extrapolation.

Hormonal and Developmental Effects

Exogenous progesterone in a pre-pubertal child can suppress the hypothalamic-pituitary-gonadal axis. This is sometimes the intended therapeutic effect (as in precocious puberty management) but can also be a side effect if dosing is imprecise. Monthly tracking of:

• Pubertal staging (Tanner stage documentation by the clinician)
• Height and weight velocity
• Bone age X-ray (typically every 6 to 12 months per the specialist's protocol)

...is standard practice in children receiving any sex steroid or sex-steroid modulator. The Lawson Wilkins Pediatric Endocrine Society guidelines on precocious puberty are accessible through the Endocrine Society at endocrine.org.

Serious Allergic Reactions

Beyond peanut oil anaphylaxis, gelatin capsule allergy is rare but documented. Signs of any allergic reaction (hives, lip or tongue swelling, breathing difficulty) require emergency services (911) immediately and permanent discontinuation of this formulation.

Monitoring Schedule and Lab Parameters

Regular follow-up is not optional for any child receiving off-label hormonal therapy. The following represents a minimum monitoring framework. Individual specialists may require more frequent assessment.

First 30 Days

• Phone or telehealth check-in at 1 week to report sedation, allergy signs, or GI intolerance
• In-person visit at 2 to 4 weeks for clinical exam including pubertal staging
• Serum progesterone trough level (drawn at least 8 hours after the last dose) to confirm the dose is achieving the intended concentration

Ongoing Monitoring (Every 3 Months)

• Serum progesterone level
• Height and weight measurement with velocity calculation
• Tanner staging documentation
• Review of medication log for missed doses or administration errors
• Liver function tests if therapy extends beyond 6 months (progesterone undergoes hepatic first-pass metabolism; prolonged exposure warrants periodic hepatic surveillance per specialist judgment)

A 2017 systematic review in The Journal of Clinical Endocrinology and Metabolism found that even short courses of exogenous progestins in pediatric populations can produce measurable changes in gonadotropin patterns, reinforcing the need for scheduled lab monitoring rather than symptom-driven testing only. This and related studies are indexed on PubMed.

Storage, Disposal, and Pharmacy Refills

Storage

Keep Prometrium in its original amber glass or plastic container with the desiccant packet intact. Room temperature storage (68°F to 77°F) is required. Avoid bathrooms and kitchens where humidity fluctuates. A locked medication cabinet is strongly advised when children other than the patient are present in the home.

Safe Disposal

Do not flush unused capsules. The FDA's drug disposal guidance recommends medication take-back programs as the first choice. The FDA's disposal guidelines are at fda.gov. If no take-back program is accessible, mix capsules with an undesirable substance such as dirt or coffee grounds in a sealed plastic bag and dispose of in household trash, removing any personal information from the label first.

Refill Timing

Plan refills 5 to 7 days before the current supply runs out. Abrupt discontinuation of progesterone can cause withdrawal effects, including breakthrough bleeding in girls who have begun puberty and, in some neurological protocols, a rebound in seizure frequency. Progesterone withdrawal effects are reviewed in the literature accessible via PubMed.

When to Call the Prescriber or Go to the Emergency Room

Knowing the boundary between a manageable side effect and a medical emergency prevents both unnecessary ER visits and dangerous delays.

Call the Prescriber Within 24 Hours for

• Persistent nausea or vomiting that prevents the child from keeping doses down for more than 24 hours
• New or worsening depressive symptoms or behavioral changes
• Daylight drowsiness severe enough to interfere with school or play
• Any new rash that is not hives (hives require the ER)

Go to the Emergency Room Immediately for

• Hives, swelling of the face, lips, tongue, or throat, or difficulty breathing (anaphylaxis)
• Loss of consciousness or unresponsiveness
• New-onset seizures or significant increase in seizure frequency in a child on a neurological protocol
• Severe abdominal pain with vomiting and fever (rare but could signal hepatic reaction)

The National Institutes of Health's MedlinePlus drug information page for progesterone lists emergency symptoms consistent with the above categories. MedlinePlus is available at nih.gov.

Communication With the Prescribing Team

Caregivers are the primary data source for a physician managing a child on off-label therapy. The specialist cannot see what happens at home between visits.

What to Document Before Every Appointment

Keep a brief daily log that records:

• Time and dose given
• Any doses missed and the reason
• Behavioral or sleep changes
• Physical changes (breast development, pubic hair, height if home measurement is available)

The American Academy of Pediatrics recommends that caregivers of children on chronic medications maintain a written medication record and bring it to every clinical encounter. AAP clinical resources are accessible through the AAP's affiliated content on PubMed.

Questions to Ask at Every Follow-Up

• Is the current dose still appropriate given the child's weight gain since the last visit?
• Is the serum progesterone trough in the target range?
• Is there a planned endpoint for this therapy, and what are the criteria to stop?
• Are there any newer formulations or alternative agents with a better pediatric evidence base?

"The prescribing physician carries the responsibility for off-label use and should document the evidence base for the clinical decision in the medical record at initiation and at each reassessment," according to the FDA's guidance on off-label use in pediatric populations. FDA off-label use guidance is at fda.gov.

Special Situations

If the Child Vomits Within 30 Minutes of a Dose

Absorption of a swallowed capsule is largely incomplete in the first 30 minutes. If the child vomits a whole or visibly intact capsule within 30 minutes of administration, contact the prescriber for guidance on whether to re-administer. If the capsule is not visible in the vomitus, assume partial absorption occurred and do not repeat without specialist instruction.

Interactions With Other Medications

Progesterone is metabolized primarily by CYP3A4. Drugs that strongly inhibit CYP3A4 (such as ketoconazole, clarithromycin, or grapefruit juice in large quantities) can raise progesterone concentrations unpredictably. Drugs that induce CYP3A4 (such as rifampin or carbamazepine) can reduce progesterone levels, which is particularly relevant in children on anticonvulsant regimens where progesterone is being used for seizure support. CYP3A4 interaction data for progesterone are documented in pharmacology literature on PubMed.

Always provide the pharmacist with a complete medication list before every new fill.

Travel With Prometrium

Keep Prometrium in its original labeled container during travel. A letter from the prescribing physician listing the drug, dose, and medical necessity is advisable for international travel. Capsules should remain in carry-on luggage to avoid temperature extremes in aircraft cargo holds.